Načítá se...
Thrombopoietin receptor agonists for prevention and treatment of chemotherapy‐induced thrombocytopenia in patients with solid tumours
BACKGROUND: Chemotherapy‐induced thrombocytopenia (CIT) is defined as a peripheral platelet count less than 100×10(9)/L, with or without bleeding in cancer patients receiving myelosuppressive chemotherapy. CIT is a significant medical problem during chemotherapy, and it carries the risk of sub‐optim...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2017
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486270/ https://ncbi.nlm.nih.gov/pubmed/29178132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012035.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|